microRNA information: hsa-miR-423-3p

SectionIDlink
Mature name: hsa-miR-423-3pmiRbase
Accession: MIMAT0001340miRbase
Precursor name: hsa-mir-423 miRbase
Precursor accession: MI0001445miRbase
Symbol: MIR423HGNC
RefSeq ID: NR_029945GenBank
Sequence: AGCUCGGUCUGAGGCCCCUCAGU



Reported expression in cancers: hsa-miR-423-3p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-423-3p

breast cancerupregulation"MicroRNA sequence and expression analysis in breas ......"21586611RNA-Seq
hsa-miR-423-3p

colorectal cancerupregulation"MiR 423 3p enhances cell growth through inhibition ......"26402653qPCR
hsa-miR-423-3p

endometrial cancerderegulation"In endometrial cancer cells expression levels of m ......"26535032
hsa-miR-423-3p

esophageal cancerupregulation"In our study three miRNA-related SNPs: rs6505162 A ......"24205249
hsa-miR-423-3p

head and neck cancerderegulation"A global miRNA profiling was done on 51 formalin-f ......"20145181Reverse transcription PCR
hsa-miR-423-3p

liver cancerupregulation"MicroRNA 423 promotes cell growth and regulates G1 ......"21890460



Reported cancer pathway affected by hsa-miR-423-3p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-423-3p

colorectal cancercell cycle pathway"MiR 423 3p enhances cell growth through inhibition ......"26402653Cell proliferation assay; Cell Proliferation Assay; Transwell assay; Luciferase
hsa-miR-423-3p

head and neck cancercell cycle pathway"A global miRNA profiling was done on 51 formalin-f ......"20145181Flow cytometry
hsa-miR-423-3p

liver cancercell cycle pathway"MicroRNA 423 promotes cell growth and regulates G1 ......"21890460



Reported cancer prognosis affected by hsa-miR-423-3p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-423-3p

breast cancermetastasis"MicroRNA sequence and expression analysis in breas ......"21586611
hsa-miR-423-3p

breast cancertumorigenesis"Genetic analysis and preliminary function study of ......"25663458
hsa-miR-423-3p

breast cancerworse prognosis; drug resistance"The aim of this study was to investigate the role ......"27746365
hsa-miR-423-3p

colorectal cancermetastasis; recurrence"Also single nucleotide polymorphisms of genes enco ......"23173124
hsa-miR-423-3p

colorectal cancertumorigenesis"MiR 423 3p enhances cell growth through inhibition ......"26402653Cell proliferation assay; Cell Proliferation Assay; Transwell assay; Luciferase
hsa-miR-423-3p

endometrial cancermetastasis; tumorigenesis"In endometrial cancer cells expression levels of m ......"26535032
hsa-miR-423-3p

liver cancertumorigenesis; progression"MicroRNA 423 promotes cell growth and regulates G1 ......"21890460
hsa-miR-423-3p

liver cancerworse prognosis"Identification of miR 423 and miR 499 polymorphism ......"24854593
hsa-miR-423-3p

lung squamous cell cancermetastasis"In this study five NSCLC cases with LN metastasis ......"26618049



Reported gene related to hsa-miR-423-3p

miRNAcancergenereportingPUBMED



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-423-3p
ATP8B2
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.588; TCGA BRCA -0.285; TCGA CESC -0.223; TCGA COAD -0.72; TCGA ESCA -0.521; TCGA HNSC -0.274; TCGA KIRP -0.17; TCGA LUSC -0.321; TCGA PRAD -0.186; TCGA SARC -0.261; TCGA THCA -0.26; TCGA STAD -0.612; TCGA UCEC -0.381
hsa-miR-423-3p
CDKN1A
11 cancers: BLCA; BRCA; CESC; ESCA; LGG; LIHC; LUSC; PAAD; PRAD; THCA; STAD
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.2; TCGA BRCA -0.105; TCGA CESC -0.268; TCGA ESCA -0.325; TCGA LGG -0.248; TCGA LIHC -0.425; TCGA LUSC -0.4; TCGA PAAD -0.206; TCGA PRAD -0.227; TCGA THCA -0.177; TCGA STAD -0.123
hsa-miR-423-3p
DPYSL3
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.889; TCGA BRCA -0.2; TCGA CESC -0.411; TCGA COAD -0.924; TCGA ESCA -0.8; TCGA HNSC -0.354; TCGA KIRP -1.08; TCGA LGG -0.213; TCGA LIHC -0.419; TCGA LUSC -0.313; TCGA PAAD -0.448; TCGA PRAD -0.489; TCGA SARC -0.557; TCGA STAD -0.867; TCGA UCEC -0.682
hsa-miR-423-3p
EEF1A1
11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.156; TCGA BRCA -0.09; TCGA ESCA -0.177; TCGA HNSC -0.06; TCGA KIRC -0.121; TCGA KIRP -0.209; TCGA LGG -0.154; TCGA LUAD -0.186; TCGA LUSC -0.072; TCGA PAAD -0.176; TCGA STAD -0.124
hsa-miR-423-3p
EIF4B
9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.132; TCGA BRCA -0.081; TCGA HNSC -0.124; TCGA KIRC -0.135; TCGA KIRP -0.268; TCGA LGG -0.157; TCGA LUAD -0.138; TCGA STAD -0.073; TCGA UCEC -0.097
hsa-miR-423-3p
FOXJ2
11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.184; TCGA CESC -0.103; TCGA COAD -0.07; TCGA HNSC -0.081; TCGA KIRP -0.234; TCGA LIHC -0.156; TCGA LUAD -0.088; TCGA PRAD -0.124; TCGA SARC -0.119; TCGA STAD -0.163; TCGA UCEC -0.265
hsa-miR-423-3p
FRMD4A
11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUSC; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.138; TCGA CESC -0.158; TCGA COAD -0.234; TCGA HNSC -0.091; TCGA KIRP -0.499; TCGA LUSC -0.462; TCGA PAAD -0.217; TCGA PRAD -0.083; TCGA THCA -0.164; TCGA STAD -0.304; TCGA UCEC -0.134
hsa-miR-423-3p
KDSR
10 cancers: BLCA; CESC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; UCEC
miRNAWalker2 validate
TCGA BLCA -0.11; TCGA CESC -0.106; TCGA KIRP -0.104; TCGA LIHC -0.165; TCGA LUAD -0.1; TCGA PAAD -0.141; TCGA PRAD -0.157; TCGA SARC -0.162; TCGA THCA -0.051; TCGA UCEC -0.176
hsa-miR-423-3p
NACC2
15 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.383; TCGA BRCA -0.141; TCGA COAD -0.128; TCGA ESCA -0.332; TCGA HNSC -0.103; TCGA KIRC -0.238; TCGA KIRP -0.442; TCGA LGG -0.204; TCGA LUSC -0.156; TCGA PAAD -0.169; TCGA PRAD -0.333; TCGA SARC -0.439; TCGA THCA -0.283; TCGA STAD -0.427; TCGA UCEC -0.154
hsa-miR-423-3p
NTN1
12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.815; TCGA CESC -0.349; TCGA COAD -0.701; TCGA ESCA -0.875; TCGA HNSC -0.267; TCGA KIRC -0.92; TCGA KIRP -1.384; TCGA LIHC -0.285; TCGA PRAD -0.651; TCGA SARC -0.465; TCGA THCA -0.641; TCGA STAD -1.095
hsa-miR-423-3p
REEP2
10 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.605; TCGA COAD -0.688; TCGA ESCA -0.756; TCGA KIRC -0.679; TCGA KIRP -0.995; TCGA LGG -0.255; TCGA PRAD -0.372; TCGA SARC -0.529; TCGA STAD -1.128; TCGA UCEC -0.17
hsa-miR-423-3p
RNF185
9 cancers: BLCA; ESCA; HNSC; KIRP; LGG; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.058; TCGA ESCA -0.092; TCGA HNSC -0.06; TCGA KIRP -0.121; TCGA LGG -0.11; TCGA PRAD -0.101; TCGA SARC -0.23; TCGA STAD -0.118; TCGA UCEC -0.094
hsa-miR-423-3p
ROBO1
11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.306; TCGA COAD -0.287; TCGA HNSC -0.16; TCGA KIRC -0.209; TCGA KIRP -0.767; TCGA LGG -0.441; TCGA LUAD -0.135; TCGA PAAD -0.476; TCGA PRAD -0.521; TCGA THCA -0.328; TCGA STAD -0.383
hsa-miR-423-3p
SMARCA2
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.182; TCGA BRCA -0.076; TCGA CESC -0.144; TCGA COAD -0.1; TCGA ESCA -0.26; TCGA HNSC -0.255; TCGA KIRC -0.289; TCGA KIRP -0.46; TCGA LGG -0.18; TCGA LIHC -0.49; TCGA LUAD -0.152; TCGA PRAD -0.142; TCGA SARC -0.176; TCGA STAD -0.267; TCGA UCEC -0.291
hsa-miR-423-3p
SPTBN1
10 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; PRAD; THCA; UCEC
miRNAWalker2 validate
TCGA BLCA -0.149; TCGA HNSC -0.253; TCGA KIRC -0.168; TCGA KIRP -0.344; TCGA LIHC -0.203; TCGA LUSC -0.37; TCGA PAAD -0.267; TCGA PRAD -0.236; TCGA THCA -0.134; TCGA UCEC -0.155
hsa-miR-423-3p
WNK1
10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.135; TCGA CESC -0.229; TCGA HNSC -0.202; TCGA KIRC -0.347; TCGA KIRP -0.743; TCGA LUAD -0.112; TCGA PRAD -0.103; TCGA THCA -0.124; TCGA STAD -0.081; TCGA UCEC -0.097
hsa-miR-423-3p
YIPF5
9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; THCA
miRNAWalker2 validate
TCGA BLCA -0.07; TCGA COAD -0.103; TCGA ESCA -0.124; TCGA HNSC -0.101; TCGA KIRP -0.181; TCGA LUAD -0.117; TCGA LUSC -0.165; TCGA PRAD -0.075; TCGA THCA -0.062
hsa-miR-423-3p
EMCN
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.468; TCGA BRCA -0.493; TCGA CESC -0.735; TCGA COAD -0.731; TCGA ESCA -0.575; TCGA HNSC -0.569; TCGA KIRC -0.643; TCGA KIRP -1.354; TCGA LIHC -0.751; TCGA LUAD -0.299; TCGA LUSC -1.106; TCGA PAAD -0.431; TCGA PRAD -0.296; TCGA SARC -0.23; TCGA STAD -0.521; TCGA UCEC -0.968
hsa-miR-423-3p
CBX7
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.465; TCGA BRCA -0.49; TCGA CESC -0.301; TCGA COAD -0.266; TCGA ESCA -0.53; TCGA HNSC -0.316; TCGA KIRC -0.27; TCGA KIRP -0.601; TCGA LGG -0.191; TCGA LIHC -0.281; TCGA LUAD -0.101; TCGA LUSC -0.33; TCGA PRAD -0.306; TCGA SARC -0.852; TCGA STAD -0.736; TCGA UCEC -0.744
hsa-miR-423-3p
FRY
17 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC
MirTarget; PITA
TCGA BLCA -0.256; TCGA BRCA -0.194; TCGA COAD -0.482; TCGA ESCA -0.74; TCGA HNSC -0.598; TCGA KIRC -0.624; TCGA KIRP -0.965; TCGA LGG -0.31; TCGA LIHC -0.265; TCGA LUAD -0.143; TCGA LUSC -0.629; TCGA PAAD -0.267; TCGA PRAD -0.374; TCGA SARC -0.844; TCGA THCA -0.128; TCGA STAD -0.469; TCGA UCEC -0.571
hsa-miR-423-3p
ZBTB46
10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; STAD; UCEC
MirTarget
TCGA BLCA -0.191; TCGA BRCA -0.113; TCGA COAD -0.425; TCGA ESCA -0.355; TCGA HNSC -0.278; TCGA KIRC -0.207; TCGA KIRP -0.271; TCGA LUSC -0.655; TCGA STAD -0.086; TCGA UCEC -0.503
hsa-miR-423-3p
AKAP2
14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC
PITA
TCGA BLCA -0.887; TCGA BRCA -0.186; TCGA COAD -0.393; TCGA ESCA -0.536; TCGA HNSC -0.885; TCGA KIRC -0.248; TCGA KIRP -0.942; TCGA LUAD -0.175; TCGA LUSC -1.22; TCGA PAAD -0.359; TCGA PRAD -0.706; TCGA SARC -0.592; TCGA THCA -0.585; TCGA UCEC -0.857
hsa-miR-423-3p
DLL1
10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; PRAD; STAD; UCEC
PITA
TCGA BLCA -0.216; TCGA BRCA -0.498; TCGA HNSC -0.165; TCGA KIRC -0.252; TCGA KIRP -1.189; TCGA LGG -0.56; TCGA LIHC -0.608; TCGA PRAD -0.145; TCGA STAD -0.156; TCGA UCEC -0.429
hsa-miR-423-3p
ZNF561
11 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD
miRNAWalker2 validate
TCGA CESC -0.143; TCGA COAD -0.068; TCGA ESCA -0.164; TCGA HNSC -0.13; TCGA KIRC -0.126; TCGA KIRP -0.14; TCGA LIHC -0.155; TCGA LUAD -0.114; TCGA PRAD -0.12; TCGA SARC -0.193; TCGA STAD -0.098
hsa-miR-423-3p
RAB14
10 cancers: CESC; COAD; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; UCEC
MirTarget; PITA
TCGA CESC -0.095; TCGA COAD -0.061; TCGA KIRC -0.153; TCGA KIRP -0.166; TCGA LGG -0.126; TCGA LIHC -0.137; TCGA LUAD -0.115; TCGA LUSC -0.063; TCGA OV -0.115; TCGA UCEC -0.067
hsa-miR-423-3p
CYFIP2
10 cancers: ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA ESCA -0.45; TCGA HNSC -0.354; TCGA KIRC -0.544; TCGA KIRP -0.363; TCGA LGG -0.228; TCGA LUAD -0.159; TCGA LUSC -0.605; TCGA SARC -0.758; TCGA STAD -0.363; TCGA UCEC -0.185





Enriched cancer pathways of putative targets